We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS Office of Inspector General Calls for More Biosimilar Coverage in Medicare Part D
HHS Office of Inspector General Calls for More Biosimilar Coverage in Medicare Part D
The Office of Inspector General (OIG) within the Department of Health and Human Services has called for the increased use of biosimilars to reduce spending by the federal government’s Medicare Part D prescription drug program.